Synimmune GmbH: Clinical Trials

1 trial sponsored by Synimmune GmbH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Synimmune GmbH: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FLYSYN in MRD Positive AML
FLYSYN - Acute Myeloid Leukemia
Phase 1 / Phase 2CompletedSynimmune GmbH312017-02-072023-12-28

Conditions studied

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Pathologic Complete Response (1)

Countries

Germany (1)

Top investigators

Helmut Salih, Prof. Dr. (1)

Results publications

PMID 37587502